Clinical Trial Update: Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan Dose Response Clinical Trial [Phase 2]

View source ↗

Summary

This document reports results from a Phase 2 dose-response trial of dextromethorphan for central neuropathic pain and allodynia in spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allodynia
• Central Neuropathic Pain
• Spinal Cord Injury

Drugs mentioned

• Dextromethorphan (dextromethorphan)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Central Neuropathic Pain, Allodynia | Phase 2 | Status: COMPLETED | Results posted: 2017-04-04